Detalles de la búsqueda
1.
A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.
J Neurooncol
; 167(3): 407-413, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38539006
2.
Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells.
Lab Invest
; 101(3): 292-303, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262438
3.
SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours.
J Cell Mol Med
; 23(12): 8219-8232, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31560832
4.
A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer.
BMC Biol
; 16(1): 3, 2018 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29329541
5.
Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab.
Biochim Biophys Acta
; 1862(4): 601-610, 2016 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26854735
6.
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
Lancet Oncol
; 17(6): 791-800, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27179402
7.
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Oncologist
; 21(2): 150-5, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26786263
8.
Genetic variants in the renin-angiotensin system predict response to bevacizumab in cancer patients.
Eur J Clin Invest
; 45(12): 1325-32, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26509357
9.
Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology.
Clin Transl Oncol
; 26(1): 98-108, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316754
10.
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Clin Transl Oncol
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578537
11.
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Lancet Oncol
; 13(1): 25-32, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22153890
12.
Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis.
Clin Cancer Res
; 29(8): 1468-1476, 2023 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36716289
13.
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
Neuro Oncol
; 25(1): 157-166, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35639825
14.
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Ther Adv Med Oncol
; 15: 17588359221148921, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36743520
15.
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy.
Biomed Pharmacother
; 167: 115592, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778272
16.
Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors.
Breast Cancer Res
; 14(6): R153, 2012 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23216744
17.
SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021).
Clin Transl Oncol
; 24(4): 693-702, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35362851
18.
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.
Int J Environ Res Public Health
; 19(19)2022 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36231341
19.
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
Eur J Cancer
; 168: 12-24, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429901
20.
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
Mol Oncol
; 16(12): 2355-2366, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34816585